Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-05-01T06:52:41.530Z Has data issue: false hasContentIssue false
  • English
  • Français

Of mice and men: genetic determinants of iron status

Published online by Cambridge University Press:  07 March 2007

Johanne McGregor ,
Andrew T. McKie  and
Robert J. Simpson
Johanne McGregor
Affiliation:
Division of Life Sciences, King's College London, London, SE1 9NN, UK
Andrew T. McKie
Affiliation:
Division of Life Sciences, King's College London, London, SE1 9NN, UK
Robert J. Simpson*
Affiliation:
Division of Life Sciences, King's College London, London, SE1 9NN, UK
*
Corresponding author: Dr Robert Simpson, fax 44 20 7848 4500, email robert.simpson@kcl.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Fe homeostasis is maintained by regulation of Fe absorption to balance largely unregulated body Fe losses. The majority of human subjects maintain relatively constant Fe stores; however, Fe deficiency and Fe overload are common conditions. Fe overload is frequently associated with mutations in genes of Fe metabolism. The present paper summarises present knowledge of these mutations as well as indicating other genes that animal studies have implicated as candidates for influencing body Fe stores.

Keywords

Iron overloadIron deficiencyIron absorption
Type
Meeting Report
Information
Proceedings of the Nutrition Society , Volume 63 , Issue 1 , February 2004 , pp. 11 - 20
Copyright
Copyright © The Nutrition Society 2004

References

Abboud, S & Haile, DJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. Journal of Biological Chemistry 275, 19906–19912.CrossRefGoogle ScholarPubMed
Adams, PC (2003) Lessons from liver transplantation: flip, flop, and why? Gut 52, 317–318.CrossRefGoogle ScholarPubMed
Aguilar-Martinez, P, Esculie-Coste, C, Bismuth, M, Giansily-Blaizot, M, Larrey, D & Schved, JF (2001) Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Blood Cells, Molecules and Diseases 27, 290–293.CrossRefGoogle ScholarPubMed
Andrews, NC (2000) Iron homeostasis: insights from genetics and animal models. Nature Reviews in Genetics 1, 208–217.CrossRefGoogle ScholarPubMed
Barton, EH, West, PA, Rivers, CA, Barton, JC & Acton, RT (2001) Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload. Blood Cells, Molecules and Diseases 27, 279–284.CrossRefGoogle ScholarPubMed
Barton, JC, Sawada-Hirai, R, Rothenberg, BE & Acton, RT (1999) Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells, Molecules and Diseases 25, 147–155.CrossRefGoogle ScholarPubMed
Beutler, E, Barton, JC, Jelitti, VJ, Gelbart, T, West, C, Lee, PL, Waalen, J & Vulpe, C (2003) Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells, Molecules and Diseases 31, 305–309.CrossRefGoogle ScholarPubMed
Beutler, E, Felitti, V, Gelbart, T & Waalen, J (2003) Haematological effects of the C282YHFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry. British Journal of Haematology 120, 887–893.CrossRefGoogle Scholar
Beutler, E, Gelbart, T, Lee, P, Trevino, R, Fernandez, MA & Fairbanks, VF (2000) Molecular characterization of a case of atransferrinemia. Blood 96, 4071–4074.CrossRefGoogle ScholarPubMed
Bosio, S, De Gobbi, M, Roetto, A, Zecchina, G, Leonardo, E, Rizzetto, M, Lucetti, C, Petrozzi, L, Bonuccelli, U & Camaschella, C (2002) Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. Blood 100, 2246–2248.CrossRefGoogle ScholarPubMed
Bridle, KR, Frazer, DM, Wilkins, SJ, Dixon, JL, Purdie, DM, Crawford, DH, Subramaniam, VN, Powell, LW, Anderson, GJ & Ram, GA (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669–673.CrossRefGoogle ScholarPubMed
Camaschella, C (1998) Juvenile haemochromatosis. Bailliara's Clinical Gastroenterology 12, 227–235.CrossRefGoogle ScholarPubMed
Camaschella, C, Roetto, A, Cali, A, De Gobbi, M, Garozzo, G, Carella, M, Majorano, N, Totaro, A & Gasparini, P (2000 a) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nature Genetics 25, 14–15.CrossRefGoogle Scholar
Camaschella, C, Zecchina, G, Lockitch, G, Roetto, A, Campanella, A, Arosio, P & Levi, S (2000 b) A new mutation (G51C) in the iron-responsive element (IRE) of L-ferritin associated with hyperferritinaemia-cataract syndrome decreases the binding affinity of the mutated IRE for iron-regulatory proteins. British Journal of Haematology 108, 480–482.CrossRefGoogle ScholarPubMed
Cazzola, M, Cremonesi, L, Papaioannou, M, Soriani, N, Kioumi, A, Charalambidou, A, Paroni, R, Romtsou, K, Levi, S, Ferrari, M, Arosio, P & Christakis, J (2002) Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). British Journal of Haematology 119, 539–546.CrossRefGoogle ScholarPubMed
Cremonisi, L, Paroni, R, Foglieni, B, Galbiati, S, Fermo, I, Soriani, N, Belloli, S, Ruggeri, G, Biasiotto, G, Cazzola, M, Ferrari, F, Ferrari, M & Arosio, P (2003) Scanning mutations of the 5'UTR regulatory sequence of L-ferritin by denaturing high-performance liquid chromatography: identification of new mutations. British Journal of Haematology 121, 173–179.CrossRefGoogle Scholar
Datz, C, Haas, T, Rinner, H, Sandhofer, F, Patsch, W & Paulweber, B (1998) Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron transferrin saturation and hemoglobin in young women: a protective role against iron deficiency. Clinical Chemistry 44, 2429–2432.CrossRefGoogle ScholarPubMed
Davies, PS, Zhang, AS, Anderson, EL, Roy, CN, Lampson, MA, McGraw, TE & Enns, CA (2003) Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments. Biochemical Journal 373, 145–153.CrossRefGoogle ScholarPubMed
Devalia, V, Carter, K, Walker, AP, Perkins, SJ, Worwood, M, May, A & Dooley, JS (2002) Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 100, 695–697.CrossRefGoogle ScholarPubMed
de Villiers, JN, Hillermann, R, Loubser, L & Kotze, MJ (1999) Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria. Human Molecular Genetics 8, 1517–1522.CrossRefGoogle ScholarPubMed
Donovan, A, Brownlie, A, Zhou, Y, Shepard, J, Pratt, SJ, Moynihan, J et al. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776–781.CrossRefGoogle ScholarPubMed
Dupic, F, Fruchon, S, Bensaid, M, Borot, N, Radosavljevic, M, Loreal, O, Brissot, P, Gilfillan, S, Bahram, S, Coppin, H & Roth, MP (2002) Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains. Gastroenterology 122, 745–751.CrossRefGoogle ScholarPubMed
Feder, JN, Gnirke, A, Thomas, W, Tsuchihashi, Z, Ruddy, DA, Basava, F et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genetics 13, 399–408.CrossRefGoogle ScholarPubMed
Feder, JN, Penny, DM, Irrinki, A, Lee, VK, Lebron, JA, Watson, N, Tsuchihashi, Z, Sigal, E, Bjorkman, PJ & Schatzman, RC (1998) The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proceedings of the National Academy of Sciences USA 95, 1472–1477.CrossRefGoogle ScholarPubMed
Finch, C (1994) Regulators of iron balance in humans. Blood 84, 1697–1702.CrossRefGoogle ScholarPubMed
Fleming, DJ, Tucker, KL, Jacques, PF, Dallal, GE, Wilson, PWF & Wood, RJ (2002) Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort. American Journal of Clinical Nutrition 76, 1375–1384.CrossRefGoogle ScholarPubMed
Fleming, RE, Migas, MC, Holden, CC, Waheed, A, Britton, RS, Tomatsu, S, Bacon, BR & Sly, WS (2000) Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proceedings of the National Academy of Sciences USA 97, 2214–2219.CrossRefGoogle ScholarPubMed
Frazer, DM & Anderson, GJ (2003) The orchestration of body iron intake: how and where do enterocytes receive their cues. Blood Cells, Molecules and Diseases 30, 288–297.CrossRefGoogle ScholarPubMed
Fuchs, J, Podda, M, Packer, L & Kaufmann, R (2002) Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes. Toxicology 180, 169–181.CrossRefGoogle ScholarPubMed
Girelli, D, Bozzini, C, Roetto, A, Alberti, F, Daraio, F, Colombari, R, Olivieri, O, Corrocher, R & Camaschella, C (2002) Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastroenterolgy 122, 1295–1302.CrossRefGoogle ScholarPubMed
Gordeuk, VR, Caleffi, A, Carradini, E, Ferrara, F, Jones, RA, Castro, O et al. (2003) Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells, Molecules and Diseases 31, 299–304.CrossRefGoogle Scholar
Green, R, Charlton, R, Seftel, H, Bothwell, T, Mayet, F, Adams, B, Finch, C & Layrisse, M (1968) Body iron excretion in man. American Journal of Medicine 45, 336–353.CrossRefGoogle ScholarPubMed
Griffiths, WJ & Cox, TM (2003) Co-localization of the mammalian hemochromatosis gene product (HFE) and a newly identified transferrin receptor (TfR2) in intestinal tissue and cells. Journal of Histochemistry and Cytochemistry 51, 613–623.CrossRefGoogle Scholar
Gunshin, H, Mackenzie, B, Berger, UV, Gunshin, Y, Romero, MF, Boron, WF, Nussberger, S, Gollan, JL & Hediger, MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482–488.CrossRefGoogle ScholarPubMed
Hallberg, L (2001) Perspective on nutritional iron deficiency. Annual Reviews in Nutrition 21, 1–21.CrossRefGoogle ScholarPubMed
Halsall, DJ, McFarlane, I, Luan, J, Cox, TM & Wareham, NJ (2003) Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case–control study. Human Molecular Genetics 12, 1361–1365.CrossRefGoogle ScholarPubMed
Harris, ZL, Takahashi, Y, Miyajima, H, Serizawa, M, MacGillivray, RT & Gitlin, JD (1995) Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proceedings of the National Academy of Sciences USA 92, 2539–2543.CrossRefGoogle ScholarPubMed
Harrison, PM & Arosio, P (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochimica et Biophysica Acta 1275, 161–203.CrossRefGoogle ScholarPubMed
Hattori, A, Wakusawa, S, Hayashi, H, Harashima, A, Sanae, F, Kawanaka, M, Yamada, G, Yano, M & Yoshioka, K (2003) AVAQ 594–597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatology Research 26, 154–156.CrossRefGoogle Scholar
Hetet, G, Devaux, I, Soufir, N, Grandchamp, B & Beaumont, C (2003) Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and three new ferroportin (slc11A3) mutations. Blood 102, 1904–1910.CrossRefGoogle Scholar
Hetet, G, Elbaz, A, Gariepy, J, Nicaud, V, Arveiler, D, Morrison, C, Kee, F, Evans, A, Simon, A, Amarenco, P, Cambien, F & Grandchamp, B (2001) Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. European Journal of Clinical Investigation 31, 382–388.CrossRefGoogle ScholarPubMed
Hofmann, WK, Tong, XJ, Ajioka, RS, Kushner, JP & Koeffler, HP (2002) Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis. Blood 100, 1099–1100.CrossRefGoogle ScholarPubMed
Jouanolle, AM, Doubain-Gicquel, V, Halimi, C, Loreal, O, Fergelot, P, Delacour, T, de Lajarte-Thirouarel, AS, Turlin, B, Le Gall, JY, Cadet, E, Rochette, J, David, V & Brissot, P (2003) Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. Journal of Hepatology 39, 286–289.CrossRefGoogle ScholarPubMed
Kasvosve, I, Delanghe, JR, Gomo, ZA, Gangaidzo, IT, Khumalo, H, Wuyts, B, Mvundura, E, Saungweme, T, Moyo, VM, Boelaert, JR & Gordeuk, VR (2000) Transferrin polymorphism influences iron status in blacks. Clinical Chemistry 46, 1535–1539.CrossRefGoogle ScholarPubMed
Kato, J, Fujikawa, K, Kanda, M, Fukuda, N, Sasaki, K, Takayama, T, Kobune, M, Takada, K, Takimoto, R, Hamada, H, Ikeda, T & Niitsu, Y (2001) A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. American Journal of Human Genetics 69, 191–197.CrossRefGoogle ScholarPubMed
Kawabata, H, Yang, R, Hirama, T, Vuong, PT, Kawano, S, Gombart, AF & Koeffler, HP (1999) Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. Journal of Biological Chemistry 274, 20826–20832.CrossRefGoogle ScholarPubMed
Kelly, AL, Lunt, PW, Rodrigues, F, Berry, PJ, Flynn, DM, McKiernan, PJ Kelly, DA, Mieli-Vergani, G & Cox, TM (2001) Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. Journal of Medical Genetics 38, 599–610.CrossRefGoogle ScholarPubMed
Knisely, AS (1992) Neonatal hemochromatosis. Advances in Pediatrics 39, 383–403.CrossRefGoogle ScholarPubMed
Le Gac, GG, Dupradeau, FY, Mura, C, Jacolot, S, Scotet, V, Esnault, G, Mercier, AY, Rochette, J & Ferec, C (2003) Phenotypic expression of the C282Y/Q283P compound heterozygosity in HFE and molecular modeling of the Q283P mutation effect. Blood Cells, Molecules and Diseases 30, 231–237.CrossRefGoogle ScholarPubMed
Lee, PL, Gelbart, T, West, C, Halloran, C, Felitti, V & Beutler, E (2001 a) A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells, Molecules and Diseases 27, 783–802.CrossRefGoogle ScholarPubMed
Lee, PL, Halloran, C, Trevino, R, Felitti, V & Beutler, E (2001 b) Human transferrin G277S mutation: a risk factor for iron deficiency anaemia. British Journal of Haematology 115, 329–333.CrossRefGoogle ScholarPubMed
Lee, PL, Halloran, C, West, C & Beutler, E (2001 c) Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells, Molecules and Diseases 27, 285–289.CrossRefGoogle ScholarPubMed
Levy, JE, Montross, LK & Andrews, NC (2000) Genes that modify the hemochromatosis phenotype in mice. Journal of Clinical Investigation 105, 1209–1216.CrossRefGoogle ScholarPubMed
McKie, AT, Barrow, D, Latunde-Dada, GO, Rolfs, A, Sager, G, Mudaly, E et al. (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291, 1755–1759.CrossRefGoogle ScholarPubMed
McKie AT, AT, Marciani, P, Rolfs, A, Brennan, K, Wehr, K, Barrow, D, Miret, S, Bomford, A, Peters, TJ, Farzaneh, F, Hediger, MA, Hentze, MW & Simpson, RJ (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Molecular Cell 5, 299–309.CrossRefGoogle ScholarPubMed
McNamara, L, MacPhail, AP, Gordeuk, VR, Hasstedt, SJ & Rouault, T (1998) Is there a link between African iron overload and the described mutations of the hereditary haemochromatosis gene. British Journal of Haematology 102, 1176–1178.CrossRefGoogle Scholar
Mattman, A, Huntsman, D, Lockitch, G, Langlois, S, Buskard, N, Ralston, D, Butterfield, Y, Rodrigues, P, Jones, S, Porto, G, Marra, M, De Sousa, M & Vatcher, G (2002) Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. Blood 100, 1075–1077.CrossRefGoogle ScholarPubMed
Melis, MA, Cau, M, Deidda, F, Barella, S, Cao, A & Galanello, R (2002) H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers. Haematologica 87, 242–245.Google ScholarPubMed
Merryweather-Clarke, AT, Pointon, JJ, Jouanolle, AM, Rochette, J & Robson, KJ (2000) Geography of HFE C282Y and H63D mutations. Genetic Testing 4, 183–198.CrossRefGoogle ScholarPubMed
Merryweather-Clarke, AT, Pointon, JJ, Shearman, JD & Robson, KJ (1997) Global prevalence of putative haemochromatosis mutations. Journal of Medical Genetics 34, 275–278.CrossRefGoogle ScholarPubMed
Milman, N & Pedersen, P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clinical Genetics 64, 36–47.CrossRefGoogle ScholarPubMed
Miret, S, Simpson, RJ & Mckie, AT (2003) Physiology and molecular biology of dietary iron absorption. Annual Reviews in Nutrition 23, 283–301.CrossRefGoogle Scholar
Monaghan, KG, Rybicki, BA, Shurafa, M & Feldman, GL (1998) Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans. American Journal of Hematology 58, 213–217.3.0.CO;2-U>CrossRefGoogle ScholarPubMed
Montes-Cano, M, Gonzalez-Escribano, MF, Aguilar, J & Nunez-Roldan, A (2002) Juvenile hemochromatosis in a Spanish family. Blood Cells, Molecules and Diseases 28, 297–300.CrossRefGoogle Scholar
Montosi, G, Donovan, A, Totaro, A, Garuti, C, Pignatti, E, Cassanelli, S, Trenor, CC, Gasparini, P, Andrews, NC & Pietrangelo, A (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. Journal of Clinical Investigation 108, 619–623.CrossRefGoogle ScholarPubMed
Moyo, VM, Mandishona, E, Hasstedt, SJ, Gangaidzo, IT, Gomo, ZA, Khumalo, H, Saungweme, T, Kiire, CF, Paterson, AC, Bloom, P, MacPhail, AP, Rouault, T & Gordeuk, VR (1998) Evidence of genetic transmission in African iron overload. Blood 91, 1076–1082.Google ScholarPubMed
Murphy, S, Curran, MD, McDougall, N, Callender, ME, O'Brien, CJ & Middleton, D (1998) High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population – implications for haemochromatosis. Tissue Antigens 52, 484–488.CrossRefGoogle ScholarPubMed
Nemeth, E, Valore, EV, Territo, M, Schiller, G, Lichtenstein, A & Ganz, T (2003) Hepcidin a putative mediator of anemia of inflammation is a type II acute-phase protein. Blood 101, 2461–2463.CrossRefGoogle Scholar
Nicolas, G, Bennoun, M, Devaux, I, Beaumont, C, Grandchamp, B, Kahn, A & Vaulont, S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proceedings of the National Academy of Sciences USA 98, 8780–8785.CrossRefGoogle ScholarPubMed
Nicolas, G, Bennoun, M, Porteu, A, Mativet, S, Beaumont, C, Grandchamp, B, Sirito, M, Sawadogo, M, Kahn, A & Vaulont, S (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proceedings of the National Academy of Sciences USA 99, 4596–4601.CrossRefGoogle ScholarPubMed
Njajou, OT, Vaessen, N, Joosse, M, Berghuis, B, Van Dongen, JW, Breuning, MH, Snijders, PJ, Rutten, WP, Sandkuijl, LA, Oostra, BA, Van Duijn, CM & Heutink, P (2001) A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nature Genetics 28, 213–214.CrossRefGoogle ScholarPubMed
Papanikolaou, G, Papaioannou, M, Politou, M, Vavatsi, N, Kioumi, A, Tsiatsiou, P, Marinaki, P, Loukopoulos, D & Christakis, JI (2002) Genetic heterogeneity underlies juvenile hemochromatosis phenotype: analysis of three families of northern Greek origin. Blood Cells, Molecules and Diseases 29, 168–173.CrossRefGoogle ScholarPubMed
Papanikolaou, G, Politou, M, Terpos, E, Fourlemadis, S, Sakellaropoulos, N & Loukopoulos, D (2000) Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity. Blood Cells, Molecules and Diseases 26, 163–168.CrossRefGoogle ScholarPubMed
Papanikoloau, G, Samuels, ME, Ludwig, EH, MacDonald, MLE, Dube, MP, Andres, L et al. (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nature Genetics 36, 77–82.CrossRefGoogle Scholar
Park, CH, Valore, EV, Waring, AJ & Ganz, T (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. Journal of Biological Chemistry 276, 7806–7810.CrossRefGoogle ScholarPubMed
Parkkila, S, Waheed, A, Britton, RS, Bacon, BR, Zhou, XY, Tomatsu, S, Fleming, RE & Sly, WS (1997 a) Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proceedings of the National Academy of Sciences USA 94, 13198–13202.CrossRefGoogle ScholarPubMed
Parkkila, S, Waheed, A, Britton, RS, Feder, JN, Tsuchihashi, Z, Schatzman, RC, Bacon, BR & Sly, WS (1997 b) Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proceedings of the National Academy of Sciences USA 94, 2534–2539.CrossRefGoogle ScholarPubMed
Pietrangelo, A (2002) Physiology of iron transport and the hemochromatosis gene. American Journal of Physiology 282, G403–G414.Google ScholarPubMed
Piperno, A, Arosio, C, Fossati, L, Vigano, M, Trombini, P, Vergani, A & Mancia, G (2000) Two novel nonsense mutations of HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology 119, 441–445.CrossRefGoogle ScholarPubMed
Pointon, JJ, Wallace, D, Merryweather-Clarke, AT & Robson, KJ (2000) Uncommon mutations and polymorphisms in the hemochromatosis gene. Genetic Testing 4, 151–161.CrossRefGoogle ScholarPubMed
Ponka, P, Beaumont, C & Richardson, DR (1998) Function and regulation of transferrin and ferritin. Seminars in Hematology 35, 35–54.Google ScholarPubMed
Pratiwi, R, Fletcher, LM, Pyper, WR, Do, KA, Crawford, DH, Powell, LW & Jazwinska, EC (1999) Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression. Journal of Hepatology 31, 39–46.CrossRefGoogle ScholarPubMed
Risch, N (1997) Haemochromatosis, HFE, and genetic complexity. Nature Genetics 17, 375–376.CrossRefGoogle ScholarPubMed
Rochette, J, Pointon, JJ, Fisher, CA, Perera, G, Arambepola, M, Arichchi, DS De Silva, S, Vandwalle, JL, Monti, JP, Old, JM, Merryweather-Clarke, AT, Weatherall, DJ & Robson, KJ (1999) Multicentric origin of hemochromatosis gene (HFE) mutations. American Journal of Human Genetics 64, 1056–1062.CrossRefGoogle ScholarPubMed
Roetto, A, Papanikolaou, G, Politou, M, Alberti, F, Girelli, D, Christakis, J, Loukopoulos, D & Camaschella, C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nature Genetics 33, 21–22.CrossRefGoogle ScholarPubMed
Roetto, A, Totaro, A, Cazzola, M, Cicilano, M, Bosio, S, D'Ascola, G, Carella, M, Zelante, L, Kelly, AL, Cox, TM, Gasparini, P & Camaschella, C (1999) Juvenile hemochromatosis locus maps to chromosome 1q. American Journal of Human Genetics 64, 1388–1393.CrossRefGoogle ScholarPubMed
Roetto, A, Totaro, A, Piperno, A, Piga, A, Longo, F, Garozzo, G, Cali, A, De Gobbi, M, Gasparini, P & Camaschella, C (2001) New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 97, 2555–2560.CrossRefGoogle ScholarPubMed
Rossi, E, Bulsara, MK, Olynyk, JK, Cullen, DJ, Summerville, L & Powell, LW (2001) Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clinical Chemistry 47, 202–208.CrossRefGoogle Scholar
Santos, M, Schilham, MW, Rademakers, LHPM, Marx, JJM, de Sousa, M & Clevers, HJ (1996) Defective iron homeostasis in β2-microglobulin knock-out mice recapitulates hereditary hemochromatosis in man. Experimental Medicine 184, 1975–1985.CrossRefGoogle Scholar
Simpson, RJ, Debnam, ES, Laftah, AH, Solanky, N, Beaumont, N, Bahram, S, Schumann, K & Srai, SKS (2003) Duodenal non-heme iron content correlates with iron stores in mice, but the relationship is altered by Hfe gene knock-out. Blood 101, 3316–3318.CrossRefGoogle Scholar
Steinberg, KK, Cogswell, ME, Chang, JC, Caudill, SP, McQuillan, GM, Bowman, BA, Grummer-Strawn, LM, Sampson, EJ, Khoury, MJ & Gallagher, ML (2001) Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. Journal of the American Medical Association 285, 2216–2222.CrossRefGoogle ScholarPubMed
Sullivan, JL & Zacharski, LR (2001) Hereditary haemochromatosis and the hypothesis that iron depletion protects against ischemic heart disease. European Journal of Clinical Investigation 31, 375–377.CrossRefGoogle ScholarPubMed
Takahashi, Y, Miyajima, H, Shirabe, S, Nagataki, S, Suenaga, A & Gitlin, JD (1996) Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Human Molecular Genetics 5, 81–84.CrossRefGoogle ScholarPubMed
Vulpe, CD, Kuo, YM, Murphy, TL, Cowley, L, Askwith, C, Libina, N, Anderson, GJ & Gitschier, J (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nature Genetics 21, 195–199.CrossRefGoogle ScholarPubMed
Waheed, A, Parkkila, S, Saarnio, J, Fleming, RE, Zhou, XY, Tomatsu, S, Britton, RS, Bacon, BR & Sly, WS (1999) Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proceedings of the National Academy of Sciences USA 96, 1579–1584.CrossRefGoogle ScholarPubMed
Waheed, A, Parkkila, S, Zhou, XY, Tomatsu, S, Tsuchihashi, Z, Feder, JN, Schatzman, RC, Britton, RS, Bacon, BR & Sly, WS (1997) Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proceedings of the National Academy of Sciences USA 94, 12384–12389.CrossRefGoogle ScholarPubMed
Wallace, DF, Dooley, JS & Walker, AP (1999) A novel mutation of HFE explains the classical phenotype of genetic haemochromatosis in a C282Y heterozygote. Gastroenterology 116, 1409–1412.CrossRefGoogle Scholar
Wallace, DF, Pedersen, P, Dixon, JL, Stephenson, P, Searle, JW, Powell, LW & Subramaniam, VN (2002 a) Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 100, 692–694.CrossRefGoogle ScholarPubMed
Wallace, DF, Walker, AP, Pietrangelo, A, Clare, M, Bomford, AB, Dixon, JL, Powell, LW, Subramaniam, VN & Dooley, JS (2002 b) Frequency of the S65C mutation of HFE and iron overload in 309 subjects heterozygous for C282Y. Journal of Hepatology 36, 474–479.CrossRefGoogle ScholarPubMed
Weinberg, ED (1999) Iron loading and disease surveillance. Emerging Infectious Diseases 5, 346–352.CrossRefGoogle ScholarPubMed
West, AP Jr, Bennett, MJ, Sellers, VM, Andrews, NC, Enns, CA & Bjorkman, PJ (2000) Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. Journal of Biological Chemistry 275, 38135–38138.CrossRefGoogle ScholarPubMed
Whitfield, JB, Cullen, LM, Jazwinska, EC, Powell, LW, Heath, AC, Zhu, G, Duffy, DL & Martin, NG (2000) Effects of HFE C282Y & H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. American Journal of Human Genetics 66, 1246–1258.CrossRefGoogle Scholar
Whitfield, JB, Treloar, S, Zhu, G, Powell, LW & Martin, NG (2003) Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. British Journal of Haematology 120, 860–866.CrossRefGoogle ScholarPubMed
Wigg, AJ, Harley, H & Casey, G (2003) Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation. Gut 52, 433–435.CrossRefGoogle ScholarPubMed
Wilson, JG, Lindquist, JH, Grambow, SC, Crook, ED & Maher, JF (2003) Potential role of increased iron stores in diabetes. American Journal of the Medical Sciences 325, 332–339.CrossRefGoogle ScholarPubMed
Worwood, M, Jackson, HA, Feeney, GP, Edwards, C & Bowen, DJ (1999) A single tube heteroduplex PCR for the common HFE genotypes. Blood 94 Suppl. 1, 405a Abstr.Google Scholar
Yoshida, T, Biro, P, Cohen, T, Muller, RM & Shibahara, S (1988) Human heme oxygenase cDNA and induction of its mRNA by hemin. European Journal of Biochemistry 171, 457–461.CrossRefGoogle ScholarPubMed
Yoshida, K, Furihata, K, Takeda, S, Nakamura, A, Yamamoto, K, Morita, H, Hiyamuta, S, Ikeda, S, Shimizu, N & Yanagisawa, N (1995) A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nature Genetics 9, 267–272.CrossRefGoogle ScholarPubMed